Target (CBDY) Other Accumulated Expenses (2023 - 2026)
Target (CBDY) reported Other Accumulated Expenses of $904411.0 for Q1 2026, up 77.55% year-over-year from $509398.0 in Q1 2025, and up 9.66% quarter-over-quarter from $824738.0 in Q4 2025.
Target (CBDY) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Target (CBDY) has 4 years of Other Accumulated Expenses data on file, last reported at $904411.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $904411.0, up 77.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $904411.0 (up 77.55% YoY), and the FY2025 annual result was $824738.0, down 12.23% from the prior year.
- Other Accumulated Expenses advanced to $904411.0 in Q1 2026 per CBDY's latest filing, from $824738.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $939663.0 in Q4 2024 and troughed at $438434.0 in Q2 2023.
- A 4-year average of $708586.2 and a median of $710680.0 in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses surged 81.16% in 2024, then decreased 27.64% in 2025.
- A 4-year view of Other Accumulated Expenses shows it stood at $621682.0 in 2023, then surged by 51.15% to $939663.0 in 2024, then declined by 12.23% to $824738.0 in 2025, then grew by 9.66% to $904411.0 in 2026.
- Business Quant data shows CBDY's Other Accumulated Expenses at $904411.0 in Q1 2026, $824738.0 in Q4 2025, and $717344.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 904,411.00 |
| Dec 31, 2025 | 824,738.00 |
| Sep 30, 2025 | 717,344.00 |
| Jun 30, 2025 | 634,405.00 |
| Mar 31, 2025 | 509,398.00 |
| Dec 31, 2024 | 939,663.00 |
| Sep 30, 2024 | 904,001.00 |
| Jun 30, 2024 | 794,255.00 |
| Mar 31, 2024 | 704,016.00 |
| Dec 31, 2023 | 621,682.00 |
| Sep 30, 2023 | 510,688.00 |
| Jun 30, 2023 | 438,434.00 |